Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna inks deal to make mRNA medicines in China
02:34am, Thursday, 06'th Jul 2023
US drugmaker Moderna has signed a deal to make mRNA medicines in China as part of its first major investment in the country, despite escalating trade and political tension between Washington and Beiji
3 Value Stocks to Consider Selling Before They Do Your Portfolio In
06:17pm, Wednesday, 05'th Jul 2023
Selling value stocks is vital for investors who prioritize safeguarding their portfolios. Within portfolio management, it becomes imperative to identify the opportune moment to divest from value stock
Moderna Shares Advance After Striking mRNA Drug Development Deal With China
05:05pm, Wednesday, 05'th Jul 2023
Moderna shares rose 1.5% on Wednesday after signing an agreement with China to research, develop, and make mRNA treatments there.
Three-Stock Lunch: UPS, Moderna and Coinbase
04:24pm, Wednesday, 05'th Jul 2023
Michael Landsberg, Landsberg Bennett Private Wealth Management CIO, joins 'Power Lunch' to discuss Landsberg's thoughts on three stocks: UPS, Moderna, and Coinbase.
Markets Fall at Midday Ahead of the Release of the Fed's Latest Meeting Minutes
12:15pm, Wednesday, 05'th Jul 2023
U.S. equities declined at midday on Wednesday, July 5, 2023, ahead of the release of meeting minutes from the Fed's June policy meeting.
Moderna reaches agreement reportedly valued at up to $1B to develop mRNA drugs in China
11:23am, Wednesday, 05'th Jul 2023
Moderna has reached a memorandum of understanding and a land collaboration agreement to research, develop, and manufacture mRNA medicines in China, the company has confirmed to multiple media outlets.
Moderna stock pops after company makes regulatory submissions in U.S., Europe, Switzerland and Australia for its RSV vaccine
11:08am, Wednesday, 05'th Jul 2023
Moderna Inc.'s stock MRNA, +2.43% rose 3% Wednesday, after the company said it has made regulatory submissions in Europe, Switzerland and Australia for its mRNA-1345 vaccine which targets RSV-associat
Moderna Stock Is Surging on Deal to Make Vaccines in China
10:44am, Wednesday, 05'th Jul 2023
Drugmaker Moderna reached an agreement to produce mRNA vaccines in China. One report noted the company could invest up to $1 billion in the country.
Moderna strikes deal to develop mRNA drugs in China
09:05am, Wednesday, 05'th Jul 2023
The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers.
Moderna says it has signed deal in China with view to research and make mRNA medicines
05:36am, Wednesday, 05'th Jul 2023
Vaccine maker Moderna Inc said on Wednesday it had signed a memorandum of understanding and a land collaboration agreement to work towards opportunities for it to research, develop and manufacture mRN
Is Moderna Heading for a Critical Moment?
05:30am, Wednesday, 05'th Jul 2023
Moderna recently asked regulators for authorization of its updated coronavirus vaccine. The company says it's ramped up production and is ready to deliver doses for the fall vaccination season.
Worst Stocks Of 2023's First Half: Battered Banks And Vaccine Makers
08:07pm, Monday, 03'rd Jul 2023
The well's run dry for the sector thus far this year as energy prices stabilized.
Moderna (MRNA) Submits Filing in EU for Updated COVID-19 Jab
10:42am, Monday, 03'rd Jul 2023
Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. If the filing is approved in the EU, the vaccine will be made available for the fall season.
Moderna files for European authorization of updated COVID vaccine
02:35am, Monday, 03'rd Jul 2023
U.S. biotech firm Moderna said on Monday it had submitted a regulatory application to the European Medicines Agency (EMA) seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 s
Moderna: Declining Performance And Relative Weakness
07:03am, Friday, 30'th Jun 2023
Moderna NASDAQ: MRNA was the top-performing stock in the S&P 500 not too long ago when the company joined the index in mid-2021. At its peak in 2021, the company's value soared to $187 billion as COVI
